Intravesical cisplatin for superficial bladder tumors. 1982

M S Blumenreich, and B Needles, and A Yagoda, and P Sogani, and H Grabstald, and W F Whitmore

Cisplatin, 50-150 mg in a maximum concentration of 1 mg/ml, was administered intravesically each week to 24 patients with multiple, recurrent carcinoma in situ and/or bladder tumors confined to the mucosa and lamina propria. All patients had a history of multiple transurethral resections and four had received prior chemotherapy. Response was evaluated by urinary cytology, cystoscopy, and biopsy. In a total of 237 weekly doses, toxicities included mild dysuria, pruritus, rash and in one patient, acute anaphylaxis. Only three (13%) patients were classified as achieving complete remission. Cisplatin, in the dose and schedule employed, is ineffective in controlling superficial bladder cancer.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D001749 Urinary Bladder Neoplasms Tumors or cancer of the URINARY BLADDER. Bladder Cancer,Bladder Neoplasms,Cancer of Bladder,Bladder Tumors,Cancer of the Bladder,Malignant Tumor of Urinary Bladder,Neoplasms, Bladder,Urinary Bladder Cancer,Bladder Cancers,Bladder Neoplasm,Bladder Tumor,Cancer, Bladder,Cancer, Urinary Bladder,Neoplasm, Bladder,Neoplasm, Urinary Bladder,Tumor, Bladder,Tumors, Bladder,Urinary Bladder Neoplasm
D002278 Carcinoma in Situ A lesion with cytological characteristics associated with invasive carcinoma but the tumor cells are confined to the epithelium of origin, without invasion of the basement membrane. Carcinoma, Intraepithelial,Carcinoma, Preinvasive,Intraepithelial Neoplasms,Neoplasms, Intraepithelial,Intraepithelial Carcinoma,Intraepithelial Neoplasm,Neoplasm, Intraepithelial,Preinvasive Carcinoma
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M S Blumenreich, and B Needles, and A Yagoda, and P Sogani, and H Grabstald, and W F Whitmore
February 1994, Anti-cancer drugs,
M S Blumenreich, and B Needles, and A Yagoda, and P Sogani, and H Grabstald, and W F Whitmore
August 1984, Gan to kagaku ryoho. Cancer & chemotherapy,
M S Blumenreich, and B Needles, and A Yagoda, and P Sogani, and H Grabstald, and W F Whitmore
January 1984, Actas urologicas espanolas,
M S Blumenreich, and B Needles, and A Yagoda, and P Sogani, and H Grabstald, and W F Whitmore
November 1982, Cancer,
M S Blumenreich, and B Needles, and A Yagoda, and P Sogani, and H Grabstald, and W F Whitmore
February 1989, Gan to kagaku ryoho. Cancer & chemotherapy,
M S Blumenreich, and B Needles, and A Yagoda, and P Sogani, and H Grabstald, and W F Whitmore
January 1989, Progress in clinical and biological research,
M S Blumenreich, and B Needles, and A Yagoda, and P Sogani, and H Grabstald, and W F Whitmore
October 1987, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
M S Blumenreich, and B Needles, and A Yagoda, and P Sogani, and H Grabstald, and W F Whitmore
December 1987, The Journal of urology,
M S Blumenreich, and B Needles, and A Yagoda, and P Sogani, and H Grabstald, and W F Whitmore
October 1989, Presse medicale (Paris, France : 1983),
M S Blumenreich, and B Needles, and A Yagoda, and P Sogani, and H Grabstald, and W F Whitmore
March 1992, Ugeskrift for laeger,
Copied contents to your clipboard!